Surveillance Plus FIT for CRC Screening: Additional Costs Not Justified by Benefits
Investigators sought to determine clinical and cost effectiveness of additional colonoscopy screening in patients undergoing FIT screening for colorectal cancer.
Investigators sought to determine clinical and cost effectiveness of additional colonoscopy screening in patients undergoing FIT screening for colorectal cancer.
Waiting 10 months or longer before follow-up colonoscopy after a positive FIT result is associated with higher risk of disease as well as advanced stage at diagnosis.
CT colonography with reduced preparation had increased participation compared with full cathartic preparation CT colonography, and detection rates were approximately 3 times higher for CT colonography compared with FIT.
A stool DNA test for colorectal cancer was found to be an accurate noninvasive screening option for Alaska Native people, a population with one of the highest rates of colorectal cancer in the world, according to a recent study.
A new noninvasive technology for colon cancer screening could prove promising for African-Americans, a group at higher than average risk of colon cancer.
Fecal immunochemical tests may be as effective as colonoscopies when it comes to detecting colorectal cancer among first-degree relatives of patients with colorectal cancer.
Results of a clinical trial of a noninvasive, multitarget, stool DNA test showed unprecedented rates of precancer and cancer detection by a noninvasive test.
A new modeling study has found that people who undergo colonoscopy at age 50 years in which no precancerous polyps are found can be rescreened at age 60 years with one of three alternative methods, rather than undergoing colonoscopy every 10 years.